Details of the Drug Inactive Ingredient (DIG)
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Ziprasidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[1] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[2] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Diltiazem
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[3] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Transmembrane channel/porin (TC/P) | ||||||
DBT Name: Sodium channel alpha Nav1.4 (SCN4A) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 234422.88 nM (estimated based on the structural similarity with CHEMBL2021481 ) | [4] | ||||
Structural Similarity | Tanimoto coefficient = 1 | |||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | SCN4A_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.